Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: A multicenter open randomized phase III study

Author： Masucci Giuseppe   Broman Peter   Kelly Charles   Lindahl Sten   Malmberg Lena   Reizenstein Johan   Ålenius Martin   Lewensohn Rolf  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.22, Iss.3, 2005-09, pp. : 247-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

By Hochster H.   Speyer J.L.   Mandeli J.P.   Runowicz C.   Wadler S.   Berk G.   Wallach R.   Holland J.F.   for the New York Gynecologic Oncology Group  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 292-297

Elsevier

Access to resources Recommend Favorite

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

By Michon J.M.   Hartmann O.   Bouffet E.   Meresse V.   Coze C.   Rubie H.   Bordigoni P.   Cattiaux E.   Ward N.   Bernard J.-L.   Lemerle J.   Zucker J.-M.   Philip T.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1063-1069

Elsevier

Access to resources Recommend Favorite

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutro-penic cancer patients

By Ibrahim Ezzeldin   Al-Mulhim Fatma  

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 47-51

Humana Press, Inc

Access to resources Recommend Favorite

Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 761-765

Spandidos Publications

Access to resources Recommend Favorite

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite